In recent years, many studies had shown that miR-155 played a regulatory role in lung cancer [16], kidney cancer [17], breast cancer [18, 19], colorectal cancer [20], and other tumors by targeting Forkhead box O3 (FOXO3). Here, FOXO3 is linked to breast cancer.